HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Breast Cancer Clinical Trials

Breast Cancer Clinical Trials

We’re here for you. Call us at 844-346-7222 or

Clinical Trials for Breast Cancer Treatments

Since 1989, breast cancer death rates have been decreasing thanks to advancements in treatment and earlier detection. At Regional Cancer Care Associates, we’re proud to be pioneers in the improvement of breast cancer treatments through our clinical trials. If you’re interested in enrolling in a breast cancer clinical trial, call RCCA today at 201-669-4706.

What Are Clinical Trials?

Before a new drug, medical strategy, or device can be approved, it first must be evaluated for human use. This research process is called a clinical trial. As scientific studies, clinical trials are methodically designed to follow strict scientific standards. At the end of each trial, the data is used to determine if the new medical therapy is a safe and effective method for improving patient outcomes.

Why Should I Enroll in a Breast Cancer Clinical Trial?

If you’ve been diagnosed with breast cancer, a clinical trial can give you access to the latest advancements and innovations in treatment methods and medications. In turn, you’ll participate in a research process that may one day help improve the quality of life for thousands of women and men around the world.

It’s important to note that clinical trials are one of the final stages of a careful research process that’s been developed and tested in laboratories for a significant amount of time before being offered to humans. For your safety, all clinical trials are closely monitored by an institutional review board and scientific experts.

Before agreeing to enroll in a breast cancer clinical trial, RCCA specialists require informed consent. This means that you’ll receive in-depth information about the trial, including treatments being used, its purpose, and possible risks and benefits, prior to enrollment. And as far as the cost of care goes, you won’t need to pay a penny. The company sponsoring the clinical trial will cover the bill, making clinical trials an affordable option for those diagnosed with breast cancer.

Breast Cancer Clinical Trials at RCCA

Your wellness and safety is placed above all else at RCCA. That’s why our clinical trials start with a personalized plan. To learn if you’re a good candidate for a breast cancer clinical trial, schedule an appointment with an RCCA cancer care physician today.

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

19 Clinical Trials
Breast Cancer Clinical Trials Phase III Enrolling
nct/study# NCT05879926 / NRG-BR009

A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

Learn More
Breast Cancer Clinical Trials N/A Enrolling
nct/study# NCT07038785 / PINK

A Double Blind Observational Study to Validate the SpotitEarly Test for the Detection of Breast Cancer

Learn More
Breast Cancer Clinical Trials Phase II/III Enrolling
nct/study# NCT05256745 / RAGE-IIT

RAGE inhibition to decrease cancer therapy related cardio toxicity in women with early breast cancer

Learn More
Breast Cancer Clinical Trials Phase III Enrolling
nct/study# NCT06982521 / RLY-2608-102

A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Learn More
Breast Cancer Clinical Trials N/A Enrolling
nct/study# N/A / RW-SURVIVAL-HER2

Real-World Survival Among Patients with HER2-Positive and HER2-Low Metastatic Malignancies Who Received HER2-Targeting Agents

Learn More
Breast Cancer Clinical Trials N/A Enrolling
nct/study# NCT03111108 / 2016-0215

Endocrine disruptors, obesity, and breast density among perimenopausal women

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.